Search

Search Constraints

You searched for: Author/Creator Golan, T

Search Results

1. 1133PDA phase IIa trial to assess the safety and efficacy of BL-8040 and pembrolizumab in patients with metastatic pancreatic adenocarcinoma (PDAC). (23rd October 2018)

3. 126OOlaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial. (24th November 2019)

4. Health-related quality of life in patients with a germline BRCA mutation and metastatic pancreatic cancer receiving maintenance olaparib. (28th September 2019)

5. LBA-001Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. (2nd July 2019)

6. Measurements of $\overline{\nu}_{\mu}$ and $\overline{\nu}_{\mu} + \nu_{\mu}$ charged-current cross-sections without detected pions or protons on water and hydrocarbon at a mean anti-neutrino energy of 0.86 GeV. (2nd March 2021)

7. Measurements of ν̅μ and ν̅μ + νμ charged-current cross-sections without detected pions or protons on water and hydrocarbon at a mean anti-neutrino energy of 0.86 GeV. (2nd March 2021)

8. P-055Prolonged overall survival of metastatic gastric cancer patients with BRCA germline mutations. (20th June 2018)

9. P-055Prolonged overall survival of metastatic gastric cancer patients with BRCA germline mutations. (20th June 2018)

10. Search for neutral-current induced single photon production at the ND280 near detector in T2K. (20th June 2019)